The Research and Development team at AdvanCell Isotopes Pty Ltd focuses on advancing the Targeted Alpha Therapy platform for cancer treatment. This team collaborates to innovate and enhance radiopharmaceuticals through rigorous scientific research, development of new materials, and ensuring ethical and safety compliance in preclinical studies.
View all